Your browser doesn't support javascript.
loading
Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies.
Lorini, Luigi; Bescós Atín, Coro; Thavaraj, Selvam; Müller-Richter, Urs; Alberola Ferranti, Margarita; Pamias Romero, Jorge; Sáez Barba, Manel; de Pablo García-Cuenca, Alba; Braña García, Irene; Bossi, Paolo; Nuciforo, Paolo; Simonetti, Sara.
Afiliación
  • Lorini L; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, 25123 Brescia, Italy.
  • Bescós Atín C; Oral and Maxillofacial Department, Vall d'Hebron University Hospital, 08035 Barcelons, Spain.
  • Thavaraj S; Head and Neck Pathology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RS, UK.
  • Müller-Richter U; Comprehensive Cancer Center and Department of Oral and Maxillofacial Plastic Surgery, University Hospital of Würzburg, 97070 Würzburg, Germany and Bavarian Centre for Cancer Research, 97070 Würzburg, Germany.
  • Alberola Ferranti M; Department of Pathology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
  • Pamias Romero J; Oral and Maxillofacial Department, Vall d'Hebron University Hospital, 08035 Barcelons, Spain.
  • Sáez Barba M; Oral and Maxillofacial Department, Vall d'Hebron University Hospital, 08035 Barcelons, Spain.
  • de Pablo García-Cuenca A; Oral and Maxillofacial Department, Vall d'Hebron University Hospital, 08035 Barcelons, Spain.
  • Braña García I; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.
  • Bossi P; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, 25123 Brescia, Italy.
  • Nuciforo P; Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.
  • Simonetti S; Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.
Cancers (Basel) ; 13(15)2021 Jul 23.
Article en En | MEDLINE | ID: mdl-34359597
ABSTRACT
Oral squamous cell carcinoma (OSCC) is a very aggressive cancer, representing one of the most common malignancies worldwide. Oral potentially malignant disorders (OPMDs) regroup a variegate set of different histological lesions, characterized by the potential capacity to transform in OSCC. Most of the risk factors associated with OSCC are present also in OPMDs' development; however, the molecular mechanisms and steps of malignant transformation are still unknown. Treatment of OSCC, including surgery, systemic therapy and radiotherapy (alone or in combination), has suffered a dramatic change in last years, especially with the introduction of immunotherapy. However, most cases are diagnosed during the advanced stage of the disease, decreasing drastically the survival rate of the patients. Hence, early diagnosis of premalignant conditions (OPMDs) is a priority in oral cancer, as well as a massive education about risk factors, the understanding of mechanisms involved in malignant progression and the development of specific and more efficient therapies. The aim of this article is to review epidemiological, clinical, morphological and molecular features of OPMDs, with the purpose to lay the foundation for an exhaustive comprehension of these lesions and their ability of malignant transformation and for the development of more effective and personalized treatments.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia